Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.

Simon JarrickSigrid LundbergAdina WelanderJuan-Jesus CarreroJonas HöijerMatteo BottaiJonas F Ludvigsson

Published in: Journal of the American Society of Nephrology : JASN (2019)

Patients with IgAN have an increased mortality compared with matched controls, with one extra death per 310 person-years and a 6-year reduction in life expectancy.

Keyphrases

cardiovascular events
risk factors
type diabetes